<DOC>
	<DOCNO>NCT02551744</DOCNO>
	<brief_summary>Whether pantoprazole versus famotidine prevention recurrent peptic ulcer thienopyridine user remain unclear .</brief_summary>
	<brief_title>Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist Prevention Recurrent Peptic Ulcers</brief_title>
	<detailed_description>The aim randomize double-blind comparison study compare efficacy Proton Pump Inhibitor H2 receptor antagonist prevention recurrent peptic ulcer thienopyridine user . We plan enroll 334 thienopyridine ( clopidogrel ticlopidine ) user without baseline gastroduodenal ulcer initial endoscopy . The patient randomly assign receive either ( 1 ) pantoprazole ( 40 mg qd ) ( 2 ) famotidine ( 40 mg qd ) 6 months.The ulcer recurrence rate treatment group compare .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Histamine H2 Antagonists</mesh_term>
	<mesh_term>Histamine</mesh_term>
	<mesh_term>Histamine phosphate</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>Recent endoscopic examination ( within 2 month ) reveals normal appearance erythematous patch ( without subepithelial hemorrhage , erosion ulcer ) . Peptic ulcer ( mucosal break Â³ 5 mm diameter ) document previous endoscopic examination . Subjects received thienopyridine therapy least two week . Requiring longterm antiplatelet therapy ischemic cardiovascular disease . A history gastric duodenal surgery oversew perforation . Subjects allergic study drug . Requiring longterm treatment nonsteroidal antiinflammatory drug ( NSAIDs ) , corticosteroid , aspirin , anticoagulant agent . Pregnancy . Subjects active cancer , acute serious medical illness terminal illness . Subjects gastroesophageal reflux disease .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>histamine-2 receptor antagonist</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>thienopyridine</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>prevention</keyword>
</DOC>